Sanofi is setting a new bar for annual drug price increases, promising to keep any list price increase for one of its medicines at or below the growth rate of the National Health Expenditure, which is projected to be 5.4% in 2017.
The company announced its new pricing principles on May 9 and posted details on its website. Sanofi is...






